SMTL ID : 8flg.1

Bruton's tyrosine kinase in complex with an orthosteric inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.1: 4 residues within 4Å: Chain A: R.196, M.230, E.233, F.235 No protein-ligand interaction detected (PLIP)

1 x Y8C: N~2~-(3-chlorophenyl)-N-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]glycinamide(Non-covalent)

Y8C.2: 15 residues within 4Å: Chain A: L.42, G.43, G.48, V.49, V.50, A.62, K.64, M.65, T.108, E.109, Y.110, M.111, L.162, D.173, L.176 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.42, A:V.50, A:K.64, A:L.162, A:L.176 Hydrogen bonds: A:K.64, A:T.108, A:E.109, A:M.111, A:D.173 Halogen bonds: A:M.65

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vandeveer, G.H. et al., Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model. Bioorg.Med.Chem.Lett. (2023)

Release Date

2023-03-01

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence